The Biodistribution and Pharmacokinetics of Stealth Liposomes in Patients with Solid Tumors

ONCOLOGY

Volumn 11, Issue 10 SUPPL. 12, 1997, Pages 33-37

  Stewart, Simon ^a   Harrington, Kevin J ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN SULFATE; DAUNORUBICIN; DOXORUBICIN; INDIUM; LIPOSOME; STEALTH; UNCLASSIFIED DRUG;

BONE MARROW; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER; MICROENCAPSULATION; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; SPLEEN;

EID: 0030827548     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lasic DD, Papahadjopoulis D: Liposomes revisited. Science 267:1275-1276, 1995.
2. Gregoriades G, Swain CP, Wills EJ, et al: Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1:1313-1316, 1974.
3. Huang SK, Lee K-D, Hong K, et al: Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 52:5135-5143, 1992.
4. Huang SK, Martin FJ, Jay G, et al: Extravasation and transcytosis of liposomes in Kaposi's Sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. Am J Pathol 143:1-14, 1993.
5. Gabizon AA: Liposomal anthracyclines. Hematol Oncol Clin North Am 8:431-450, 1994.
6. Allen TM, Chonn A. Large unilamellar liposomes with low uptake by the reticulo-endothelial system. FEBS Lett 223:42-46, 1987.
7. Woking PK, Newman MS, Huang SK et al: Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in STEALTH liposomes (Doxil). Liposome Res 4:667-687, 1994.
8. Papahadjopoulos D, Allen TM, Gabizon A, et al: Sterically stabilized liposomes: Improvements in pharmacokinetics and anti-tumor therapeutic efficiency. Proc Natl Acad Sci USA 85:6949-6953, 1988.
9. Gabizon A, Castane R, Uziely B, et al: Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987-992, 1994.
10. Huang SK, Mayhew E, Giliani S, et al: Pharmacokinetics and therapeutics of Sterically stabilized liposomes in mice bearing C 26 colon carcinoma. Cancer Res 52:6774-6781, 1992.
11. Gill PS, Scadden DT, Cohen P et al: Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's Sarcoma. J Clin Oncol 14:2353-2364, 1996.
12. Northfelt DW: Liposomal anthracycline chemotherapy in the treatment of AIDS-related Kaposi's sarcoma, page 21 (this issue).
13. Stewart S, Jablonowski H, Goebel FD, et al: A randomized comparative trial of liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 1996 (in press).
14. Ransom M, O'Byrne K, Carmichael J et al: Phase II dose-finding trial of Dox-SL (Stealth Liposomal Doxorubicin Hcl) in the treatment of advanced breast cancer (abstract). Proc Amer Soc Clin Oncol 15:a161, 1996.
15. Muggia F, Hainsworth S, Jeffers S, et al: Liposomal doxorubicin (Doxil) is active against refractory ovarian cancer (abstract). Proc Amer Soc Clin Oncol 15:a781, 1996.
16. Harrison M, Tomlinson ND, Stewart S: Liposomal entrapped doxorubicin: An active agent in AIDS related Kaposi's sarcoma. J Clin Oncol 13:914-920, 1995.